ACAD Acadia Pharmaceuticals Inc

$21.61 +0.02%

Healthcare · Pharmaceutical Preparations

Acadia Pharmaceuticals Inc (ACAD) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $3.7 billion. Shares last traded at $21.61, 23.8% below their 52-week high. Over the past year the stock is down 5.3%. ACAD trades at a price-to-earnings ratio of 9.46, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 36.5%, above the peer median of -0.1%. Revenue grew 11.9% year over year.

Market Cap

$3.7B

Shares Out

171.2M

EPS (TTM)

$1.09

P/E Ratio

19.82

P/S Ratio

3.45

P/B Ratio

2.96

Dividend / Share

—

Dividend Yield

—

52-Week High

$28.35

52-Week Low

$19.68

Volume

100,890

Avg Vol (3m)

90,093.46

Performance

+1.08%

+5.49%

+4.32%

-19.35%

YTD

-17.85%

-5.32%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

51.52

SMA (50)

$21.68

SMA (200)

$23.29

Price vs SMA50

-0.34%

Price vs SMA200

-7.23%

ATR (14)

$0.91

Financials

Revenue

$1.1B

Net Income

$391M

Gross Margin

63.9%

Operating Margin

9.8%

Net Margin

36.5%

Return on Equity

31.3%

Return on Assets

24.4%

Current Ratio

3.59

Debt / Equity

0.29

Revenue Growth (YoY)

+11.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.02	2026-05-07
FY 2025	$2.30	2026-02-26
Q3 2025	$0.69	2025-11-06
Q2 2025	$0.27	2025-08-07
Q1 2026	$0.11	2026-05-07
FY 2025	$1.36	2026-02-26

Full earnings history →

Pharmaceutical Preparations peers

ACAD vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

9.46 / 16.82 med

-44% discount

P/S vs peers

3.45 / 3.54 med

-2% discount

Net margin vs peers

36.5% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.